References
- Weick JK, Jones SE, Haut A, et al: Treatment of recurrent lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): A Southwest Oncology Group Study. Cancer Treat Rep 65:611–614, 1981.
- Fisher RI, DeVita VT, Hubbard SP, et al: Prolonged diseasefree survival in Hodgkin's disease with MOPP reinduction after first relapse. Ann Intern Med 90:761–763, 1979.
- Einhorn LH, Williams SD, Stevens E, et al: Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine. Cancer 51:1348–1352, 1983.
- Tannir N, Hagemeister F, Velasquez W, et al: Long-term follOW-Up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease. J Clin Oncol 1:432–438, 1983.
- Dady PJ, McElwain TJ, Austin DE, et al: Five years' experience with Ch1 VPP: Effective low-toxicity combination chemotherapy for Hodgkin's disease. Br J Cancer 45:851–859, 1982.
- Santoro A, Bonfante V, Bonadona G: Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease. Ann Intern Med 96:139–143, 1982.
- Clamon GH, and Corder MP: ABVD treatment of MOPP failures in Hodgkin disease: A re-examination of goals of salvage therapy. Cancer Treat Rep 62:363–367, 1978.
- Krikorian JG, Portlock CS, and Rosenberg SA: Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy. Cancer 41: 2107–2111, 1978.
- Einhorn LH and Donahue J: cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87: 293–298, 1977.
- Krikorian JG, Daniels JR, Brown BW, et al: Variables for predicting serious toxicity (vinblastine dose, performance status, prior therapeutic experience): Chemotherapy for metastatic testicular cancer with cis-dichlorodiammine-platinum (II), vinblastine, and bleomycin. Cancer Treat Rep 62:1455–1463, 1978.
- Blum RH, Carter SK and Agre K: A clinical review of bleomycin-A new antineoplastic agent. Cancer 31:903–914, 1973.
- Corder MP, Elliott TE, Maguire LC, et al: Phase II study of cis-dichlorodiammineplatinum (II) in Stage IVB Hodgkin's disease. Cancer Treat Rep 63:763–766, 1979.
- F1atow FA, Ultmann JE, Hyman GA, et al: Treatment of advanced Hodgkin's disease with vinblastine (NSC-49842) or procarbazine (NSC-77213). Cancer Chemo Rep 53:39–47, 1969.
- Sohier WD, Wong RKL, Aisenberg AC: Vinblastine in the treatment of advanced Hodgkin's disease. Cancer 22:467–472, 1968.
- Devita VT, Simon RM, Hubbard SM, et al: Curability of advanced Hodgkin's disease with chemotherapy: Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med 92:587–597, 1980.
- Fisher RI, DeVita VT, Hubbard SP, et al: Prolonged disease free survival in Hodgkin's disease with MOPP reinduction after first relapse. Ann Intern Med 90:761–763, 1979.
- Dady PJ, McElwain TJ, Austin DE, et al: Five years' experience with ChlVPP: Effective low-toxicity combination chemotherapy for Hodgkin's disease. Br J Cancer 45:851–859, 1982.
- Liepman MK, Wheeler RH, Zuckerman KS, et al: Combination chemotherapy of refractory lymphoma with cis-dichlorodiamine-platinum, vinblastine, and bleomycin. Cancer 50:2736–2739, 1982.